These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29518287)

  • 1. 3D skin models for 3R research: The potential of 3D reconstructed skin models to study skin barrier function.
    Niehues H; Bouwstra JA; El Ghalbzouri A; Brandner JM; Zeeuwen PLJM; van den Bogaard EH
    Exp Dermatol; 2018 May; 27(5):501-511. PubMed ID: 29518287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tight junctions in skin barrier function and dermal absorption.
    Bäsler K; Bergmann S; Heisig M; Naegel A; Zorn-Kruppa M; Brandner JM
    J Control Release; 2016 Nov; 242():105-118. PubMed ID: 27521894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin microbiota and human 3D skin models.
    Rademacher F; Simanski M; Gläser R; Harder J
    Exp Dermatol; 2018 May; 27(5):489-494. PubMed ID: 29464787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Tight Junctions in Relation to Skin Barrier Function.
    Brandner JM
    Curr Probl Dermatol; 2016; 49():27-37. PubMed ID: 26844895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could tight junctions regulate the barrier function of the aged skin?
    Svoboda M; Bílková Z; Muthný T
    J Dermatol Sci; 2016 Mar; 81(3):147-52. PubMed ID: 26639794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of a tight junction structure generated in LbL-3D skin reconstructed by layer-by-layer cell coating technique.
    Murakami M; Akagi T; Sasano Y; Chiba T; Narita H; Shimoda H; Akashi M
    J Tissue Eng Regen Med; 2021 Sep; 15(9):798-803. PubMed ID: 34028181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
    Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
    J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffolding proteins in the development and maintenance of the epidermal permeability barrier.
    Crawford M; Dagnino L
    Tissue Barriers; 2017 Oct; 5(4):e1341969. PubMed ID: 28665776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrier function of the skin: "la raison d'être" of the epidermis.
    Madison KC
    J Invest Dermatol; 2003 Aug; 121(2):231-41. PubMed ID: 12880413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative SAXS and DSC study on stratum corneum structural organization in an epidermal cell culture model (ROC): impact of cultivation time.
    Kuntsche J; Herre A; Fahr A; Funari SS; Garidel P
    Eur J Pharm Sci; 2013 Dec; 50(5):577-85. PubMed ID: 23770376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The skin's barrier.
    Jensen JM; Proksch E
    G Ital Dermatol Venereol; 2009 Dec; 144(6):689-700. PubMed ID: 19907407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Perfusion Platform for Dynamic Cultivation of in vitro Skin Models.
    Strüver K; Friess W; Hedtrich S
    Skin Pharmacol Physiol; 2017; 30(4):180-189. PubMed ID: 28651246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro micro-physiological immune-competent model of the human skin.
    Ramadan Q; Ting FC
    Lab Chip; 2016 May; 16(10):1899-908. PubMed ID: 27098052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro models to estimate drug penetration through the compromised stratum corneum barrier.
    Engesland A; Škalko-Basnet N; Flaten GE
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1742-51. PubMed ID: 27019078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin barrier and microbiome in acne.
    Rocha MA; Bagatin E
    Arch Dermatol Res; 2018 Apr; 310(3):181-185. PubMed ID: 29147769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past, present and future of in vitro 3D reconstructed inflammatory skin models to study psoriasis.
    Niehues H; van den Bogaard EH
    Exp Dermatol; 2018 May; 27(5):512-519. PubMed ID: 29502346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
    Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
    Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice.
    Jensen JM; Schütze S; Neumann C; Proksch E
    J Invest Dermatol; 2000 Oct; 115(4):708-13. PubMed ID: 10998148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin barrier in the neonate.
    Taïeb A
    Pediatr Dermatol; 2018 Mar; 35 Suppl 1():s5-s9. PubMed ID: 29596733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.